Dioclea violacea lectin modulates the gentamicin activity against multi-resistant strains and induces nefroprotection during antibiotic exposure.
Gentamicin is an aminoglycoside antibiotic used to treat infections of various origins. In the last few decades, the constant use of gentamicin has resulted in increased bacterial resistance and nephrotoxicity in some cases. In this study, we examined the ability of Dioclea violacea lectin (DVL) in modulate the antimicrobial activity of gentamicin and reduce the nephrotoxicity induced by this drug.
The minimum inhibitory concentration (MIC) obtained for DVL against all strains studied was not clinically relevant (MIC ≥ 1,024 μg/mL). However, when DVL was combined with gentamicin, a significant increase in antibiotic action was observed against Staphylococcus aureus and Escherichia coli. DVL also reduced antibiotic tolerance in S. aureus during 10 days of continuous treatment.
In addition, DVL presented a nephroprotective effect, reducing sodium excretion, N-Gal expression and urinary protein, that are important markers of glomerular and tubular injuries. Taken together, studies of inhibition of hemagglutinating activity, fluorescence spectroscopy and molecular docking revealed that gentamicin can interact with DVL via the carbohydrate recognition domain (CRD), suggesting that the results obtained in this study may be directly related to the interaction of DVL-gentamicin and with the ability of the lectin to interact with glycans present in the cells of the peritoneum.
Antioxidant, anti-inflammatory, and antiapoptotic effects of virgin coconut oil against antibiotic drug gentamicin-induced nephrotoxicity via the suppression of oxidative stress and modulation of iNOS/NF-ĸB/caspase-3 signaling pathway in Wistar rats.
Gentamicin is an effective antibiotic against severe infections; however, its major side effect is oxidative nephrotoxicity. We explored whether virgin coconut oil (VCO) could mitigate gentamicin-induced nephrotoxicity. Rats were fed with VCO-supplemented diet for 16 days against renal toxicity induced by gentamicin (100 mg/kg bw, ip) from Day 11 to 16. Gentamicin caused marked elevated serum urea, uric acid, and creatinine levels, followed by considerable depletion in renal antioxidant enzymes, glutathione (GSH), while the malondialdehyde (MDA) level increased significantly.
- It significantly increased renal cytokines and nitric oxide (NO) levels, confirmed by renal histopathology. The expression of inducible nitric oxide synthase (iNOS), nuclear factor-kappa B (NF-ĸB), and caspase-3 was prominently increased.
- VCO-supplemented diet significantly modulated the levels of biochemical indices, downregulated the expression of NO, iNOS, NF-ĸB, caspase-3, cytokines, and alleviated histopathological lesions. VCO protects against gentamicin-induced nephrotoxicity; thus, it could be a promising dietary supplement for patients undergoing gentamicin treatment.
- PRACTICAL APPLICATIONS: Gentamicin is an efficacious clinical antibiotic used against severe infections; however, the robust body of evidence indicates that the nephrotoxic side effect constrained its use. Virgin coconut oil (VCO) is an edible oil with growing human consumption and pharmacological effects.
- Our study has reported herein, for the first time, that VCO diet prevented the nephrotoxicity of gentamicin. Dietary supplementation of this oil could be beneficial in alleviating the nephrotoxic side effect of gentamicin in patients.
Gentamicin-BSA |
|||
| 80-1453 | Fitzgerald | 1 mg | EUR 592 |
|
Description: BSA conjugated Gentamicin Hapten |
|||
Gentamicin-BSA |
|||
| 80-1454 | Fitzgerald | 1 mg | EUR 592 |
|
Description: BSA conjugated Gentamicin Hapten |
|||
Gentamicin-BSA |
|||
| 80-IG10 | Fitzgerald | 25 mg | EUR 325 |
|
Description: Conjugated Gentamicin-BSA hapten |
|||
Gentamicin-BSA |
|||
| MBS537343-25mg | MyBiosource | 25mg | EUR 505 |
Gentamicin-BSA |
|||
| MBS537343-5x25mg | MyBiosource | 5x25mg | EUR 2115 |
Gentamicin-BSA |
|||
| MBS7041680-01mg | MyBiosource | 0.1mg | EUR 135 |
Gentamicin-BSA |
|||
| MBS7041680-1mg | MyBiosource | 1mg | EUR 435 |
Gentamicin-BSA |
|||
| MBS7041680-5x1mg | MyBiosource | 5x1mg | EUR 1915 |
BSA conjugated Gentamicin Hapten |
|||
| MBS5308011-1mg | MyBiosource | 1mg | EUR 930 |
BSA conjugated Gentamicin Hapten |
|||
| MBS5308011-5x1mg | MyBiosource | 5x1mg | EUR 4035 |
BSA conjugated Gentamicin Hapten |
|||
| MBS5308012-1mg | MyBiosource | 1mg | EUR 930 |
BSA conjugated Gentamicin Hapten |
|||
| MBS5308012-5x1mg | MyBiosource | 5x1mg | EUR 4035 |
Gentamicin-BSA Conjugate |
|||
| MBS7115390-1mg | MyBiosource | 1mg | EUR 490 |
Gentamicin-BSA Conjugate |
|||
| MBS7115390-5x1mg | MyBiosource | 5x1mg | EUR 2150 |
Gentamicin-BSA Conjugate |
|||
| MBS7115391-1mg | MyBiosource | 1mg | EUR 490 |
Gentamicin-BSA Conjugate |
|||
| MBS7115391-5x1mg | MyBiosource | 5x1mg | EUR 2150 |
Gentamicin |
|||
| EM061-150ST | EWC Diagnostics | 1 unit | EUR 169.41 |
|
Description: Gentamicin |
|||
Gentamicin |
|||
| EM025-150ST | EWC Diagnostics | 1 unit | EUR 164.38 |
|
Description: Gentamicin |
|||
Gentamicin |
|||
| G272 | ABM | 10ml | EUR 70 |
Gentamicin |
|||
| HY-A0276A | MedChemExpress | Get quote | Ask for price |
|
Description: Gentamicin, an orally active aminoglycoside antibiotic, inhibits the growth of both gram-positive and gram-negative bacteria and to inhibit several strains of mycoplasma in tissue culture. Gentamicin inhibits DNase I with an IC50 of 0.57 mM[1][2][3][4]. |
|||
Gentamicin |
|||
| MBS5775176-5mg | MyBiosource | 5(mg | EUR 915 |
Gentamicin |
|||
| MBS5775176-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Gentamicin |
|||
| MD025-1PK | EWC Diagnostics | 1 unit | Ask for price |
|
Description: Gentamicin |
|||
Gentamicin |
|||
| MD061-1PK | EWC Diagnostics | 1 unit | Ask for price |
|
Description: Gentamicin |
|||
Gentamicin |
|||
| T25447-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Gentamicin |
|||
Gentamicin |
|||
| T25447-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Gentamicin |
|||
Gentamicin |
|||
| T25447-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Gentamicin |
|||
Gentamicin |
|||
| T25447-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Gentamicin |
|||
Gentamicin |
|||
| T25447-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Gentamicin |
|||
Gentamicin Solution, Gentamicin Solution, 50 mg/mL |
|||
| CCM1123-010 | Bio Basic | 10 mL | EUR 76.86 |
Gentamicin(GM) |
|||
| AT022 | Unibiotest | 1mg | EUR 1134 |
Gentamicin(GM) |
|||
| AG022 | Unibiotest | 1 mg | EUR 627.6 |
Gentamicin (PE) |
|||
| MBS6251839-01mL | MyBiosource | 0.1(mL | EUR 880 |
Gentamicin (PE) |
|||
| MBS6251839-5x01mL | MyBiosource | 5x0.1mL | EUR 3805 |
Gentamicin (AP) |
|||
| MBS6247946-01mL | MyBiosource | 0.1(mL | EUR 880 |
Gentamicin (AP) |
|||
| MBS6247946-5x01mL | MyBiosource | 5x0.1mL | EUR 3805 |
Gentamycin (Gentamicin) |
|||
| MBS614836-025mL | MyBiosource | 0.25mL | EUR 490 |
Gentamycin (Gentamicin) |
|||
| MBS614836-5x025mL | MyBiosource | 5x0.25mL | EUR 2055 |
Gentamycin (Gentamicin) |
|||
| MBS615263-025mL | MyBiosource | 0.25mL | EUR 515 |
Gentamycin (Gentamicin) |
|||
| MBS615263-5x025mL | MyBiosource | 5x0.25mL | EUR 2155 |
Gentamycin (Gentamicin) |
|||
| MBS605789-1mg | MyBiosource | 1mg | EUR 530 |
Gentamycin (Gentamicin) |
|||
| MBS605789-5x1mg | MyBiosource | 5x1mg | EUR 2230 |
Gentamycin (Gentamicin) |
|||
| MBS614871-1mg | MyBiosource | 1mg | EUR 450 |
Gentamycin (Gentamicin) |
|||
| MBS614871-5x1mg | MyBiosource | 5x1mg | EUR 1865 |
Gentamycin (Gentamicin) |
|||
| MBS600426-025mg | MyBiosource | 0.25mg | EUR 580 |
Gentamycin (Gentamicin) |
|||
| MBS600426-05mg | MyBiosource | 0.5mg | EUR 965 |
Gentamycin (Gentamicin) |
|||
| MBS600426-5x05mg | MyBiosource | 5x0.5mg | EUR 4185 |
Gentamycin (Gentamicin) |
|||
| MBS603541-05mg | MyBiosource | 0.5mg | EUR 1285 |
Gentamycin (Gentamicin) |
|||
| MBS603541-5x05mg | MyBiosource | 5x0.5mg | EUR 5640 |
Gentamicin [OVA] |
|||
| DAG4468O | Creative Diagnostics | 1 mg | EUR 520 |
|
Description: Synthetic |
|||
Gentamicin [KLH] |
|||
| DAG4484 | Creative Diagnostics | 1mg | EUR 834.75 |
|
Description: Synthetic |
|||
Gentamicin [HRP] |
|||
| DAGA-032H | Creative Diagnostics | 1mg | EUR 834.75 |
|
Description: Synthetic |
|||
Gentamicin C1a |
|||
| HY-148286 | MedChemExpress | 10 mg | EUR 77.92 |
|
Description: Gentamicin C1a is the precursor of the semi-synthetic antibiotic Etimicin, and has antibacterial activity. Gentamicin C1a is the major component of the Gentamicin complex[1][2]. |
|||
Gentamicin (HRP) |
|||
| MBS6250887-01mL | MyBiosource | 0.1(mL | EUR 880 |
Gentamicin (HRP) |
|||
| MBS6250887-5x01mL | MyBiosource | 5x0.1mL | EUR 3805 |
Gentamicin (APC) |
|||
| MBS6268799-01mL | MyBiosource | 0.1mL | EUR 880 |
Gentamicin (APC) |
|||
| MBS6268799-5x01mL | MyBiosource | 5x0.1mL | EUR 3805 |
Gentamicin (FITC) |
|||
| MBS6249892-01mL | MyBiosource | 0.1(mL | EUR 880 |
Gentamicin (FITC) |
|||
| MBS6249892-5x01mL | MyBiosource | 5x0.1mL | EUR 3805 |
Gentamicin-HRP |
|||
| 65-IG10 | Fitzgerald | 1 mg | EUR 525 |
|
Description: Conjugated Gentamicin-HRP hapten |
|||
Gentamicin-OVA |
|||
| 80-1455 | Fitzgerald | 1 mg | EUR 592 |
|
Description: OVA conjugated Gentamicin Hapten |
|||
Gentamicin-OVA |
|||
| 80-1456 | Fitzgerald | 1 mg | EUR 592 |
|
Description: OVA conjugated Gentamicin Hapten |
|||
Gentamicin-HRP |
|||
| MBS537743-1mg | MyBiosource | 1mg | EUR 680 |
Gentamicin-HRP |
|||
| MBS537743-5x1mg | MyBiosource | 5x1mg | EUR 2915 |
Gentamicin-OVA |
|||
| MBS7041681-01mg | MyBiosource | 0.1mg | EUR 135 |
Gentamicin-OVA |
|||
| MBS7041681-1mg | MyBiosource | 1mg | EUR 435 |
Gentamicin-OVA |
|||
| MBS7041681-5x1mg | MyBiosource | 5x1mg | EUR 1915 |
Gentamicin (Biotin) |
|||
| MBS6248965-01mL | MyBiosource | 0.1(mL | EUR 880 |
Gentamicin (Biotin) |
|||
| MBS6248965-5x01mL | MyBiosource | 5x0.1mL | EUR 3805 |
Gentamicin Sulfate |
|||
| 40710020-1 | Bio-WORLD | 5 g | EUR 36.51 |
Gentamicin Sulfate |
|||
| 40710020-2 | Bio-WORLD | 10 g | EUR 61.99 |
Gentamicin Sulfate |
|||
| 40710020-3 | Bio-WORLD | 25 g | EUR 117.28 |
Gentamicin Sulfate |
|||
| 16637-32 | NACALAI TESQUE | 25G | EUR 630 |
Gentamicin Sulfate |
|||
| 08975-81 | NACALAI TESQUE | 1G | EUR 77 |
Gentamicin Sulfate |
|||
| 08975-94 | NACALAI TESQUE | 5G | EUR 266 |
Gentamicin sulfate |
|||
| 329895 | MedKoo Biosciences | 1.0g | EUR 250 |
Gentamicin sulfate |
|||
| B1270-1G | Biovision | each | EUR 170.4 |
Gentamicin sulfate |
|||
| B1270-25G | Biovision | each | EUR 1136.4 |
Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.
To investigate the relationship between MIC and clinical outcome in a randomized controlled trial that compared gentamicin 240 mg plus azithromycin 1 g with ceftriaxone 500 mg plus azithromycin 1 g. MIC analysis was performed on Neisseria gonorrhoeae isolates from all participants who were culture positive before they received treatment.
Viable gonococcal cultures were available from 279 participants, of whom 145 received ceftriaxone/azithromycin and 134 received gentamicin/azithromycin. Four participants (6 isolates) and 14 participants (17 isolates) did not clear infection in the ceftriaxone/azithromycin and gentamicin/azithromycin arms, respectively. MICs were determined by Etest on GC agar base with 1% Vitox.
The geometric mean MICs of azithromycin, ceftriaxone and gentamicin were compared using logistic and linear regression according to treatment received and N. gonorrhoeae clearance.As the azithromycin MIC increased, gentamicin/azithromycin treatment was less effective than ceftriaxone/azithromycin at clearing N. gonorrhoeae.
There was a higher geometric mean MIC of azithromycin for isolates from participants who had received gentamicin/azithromycin and did not clear infection compared with those who did clear infection [ratio 1.95 (95% CI 1.28-2.97)], but the use of categorical MIC breakpoints did not accurately predict the treatment response.
The geometric mean MIC of azithromycin was higher in isolates from the pharynx compared with genital isolates.We found that categorical resistance to azithromycin or ceftriaxone in vitro, and higher gentamicin MICs in the absence of breakpoints, were poorly predictive of treatment failure.
Gentamicin Sulfate |
|||
| 08975-94 | NACALAI TESQUE | 5G | EUR 266 |
Gentamicin sulfate |
|||
| 329895 | MedKoo Biosciences | 1.0g | EUR 250 |
Gentamicin Sulfate |
|||
| 40710020-1 | Bio-WORLD | 5 g | EUR 36.51 |
Gentamicin Sulfate |
|||
| 40710020-2 | Bio-WORLD | 10 g | EUR 61.99 |
Gentamicin Sulfate |
|||
| 40710020-3 | Bio-WORLD | 25 g | EUR 117.28 |
Gentamicin Sulfate |
|||
| 16637-32 | NACALAI TESQUE | 25G | EUR 630 |
Gentamicin sulfate |
|||
| B1270-1G | Biovision | each | EUR 170.4 |
Gentamicin sulfate |
|||
| B1270-25G | Biovision | each | EUR 1136.4 |
Gentamicin sulfate |
|||
| B1270-5G | Biovision | each | EUR 405.6 |
Gentamicin (sulfate) |
|||
| HY-A0276 | MedChemExpress | 500mg | EUR 64.94 |
|
Description: Gentamicin sulfate, an orally active aminoglycoside antibiotic, inhibits the growth of both gram-positive and gram-negative bacteria and to inhibit several strains of mycoplasma in tissue culture. Gentamicin sulfate inhibits DNase I with an IC50 of 0.57 mM[1][2][3][4]. |
|||
Gentamicin sulfate |
|||
| GA7939 | Glentham Life Sciences | 1g | EUR 115.8 |
Gentamicin sulfate |
|||
| GA7939-1 | Glentham Life Sciences | 1 | EUR 15.9 |
Gentamicin sulfate |
|||
| GA7939-10 | Glentham Life Sciences | 10 | EUR 71.1 |
Gentamicin sulfate |
|||
| GA7939-10G | Glentham Life Sciences | 10 g | EUR 122.4 |
Gentamicin sulfate |
|||
| GA7939-1G | Glentham Life Sciences | 1 g | EUR 55.2 |
Gentamicin sulfate |
|||
| GA7939-25 | Glentham Life Sciences | 25 | EUR 126.5 |
Gentamicin sulfate |
|||
| GA7939-25G | Glentham Life Sciences | 25 g | EUR 189.6 |
Gentamicin sulfate |
|||
| GA7939-5 | Glentham Life Sciences | 5 | EUR 47.4 |
Gentamicin sulfate |
|||
| GA7939-5G | Glentham Life Sciences | 5 g | EUR 93.6 |
GENTAMICIN SULFATE |
|||
| G570 | PhytoTechnology Laboratories | 10G | EUR 32.75 |
Gentamicin sulfate |
|||
| T1326-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin sulfate |
|||
| T1326-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin sulfate |
|||
| T1326-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin sulfate |
|||
| T1326-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin sulfate |
|||
| T1326-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin X2 Sulfate |
|||
| 565235 | MedKoo Biosciences | 1.0mg | EUR 380 |
Gentamicin X2 Sulfate |
|||
| G360605 | Toronto Research Chemicals | 0.5mg | EUR 2223 |
|
Description: 57793-88-1 |
|||
Gentamicin B Sulfate |
|||
| G360650 | Toronto Research Chemicals | 25mg | EUR 25000 |
|
Description: 43169-50-2 |
|||
Gentamicin Sulfate EP |
|||
| G007-25G | TOKU-E | 25 g | EUR 316.27 |
|
Description: 1405-41-0 |
|||
Gentamicin Sulfate EP |
|||
| G007-5G | TOKU-E | 5 g | EUR 131.5 |
|
Description: 1405-41-0 |
|||
Gentamicin Sulfate - 1g |
|||
| PM-A4120/1 | Biosera France - Medical Scientific Equipment | 1g | EUR 5.89 |
Gentamicin Sulfate - 5g |
|||
| PM-A4120/5 | Biosera France - Medical Scientific Equipment | 5g | EUR 18.7 |
Gentamicin Sulfate USP |
|||
| G006-25G | TOKU-E | 25 g | EUR 220.51 |
|
Description: 1405-41-0 |
|||
Gentamicin Sulfate USP |
|||
| G006-5G | TOKU-E | 5 g | EUR 65.41 |
|
Description: 1405-41-0 |
|||
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-100g | MyBiosource | 100g | EUR 570 |
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-1kg | MyBiosource | 1kg | EUR 1495 |
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-25g | MyBiosource | 25g | EUR 440 |
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-500g | MyBiosource | 500g | EUR 860 |
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-5g | MyBiosource | 5g | EUR 210 |
0.1g Gentamicin Sulfate Powder |
|||
| 61-098-RA | Scientific Laboratory Supplies | EACH | EUR 58.37 |
1g Gentamicin Sulfate Powder |
|||
| 61-098-RF | Scientific Laboratory Supplies | EACH | EUR 76.38 |
Gentamicin Sulfate, Animal-Free |
|||
| 19771-01 | NACALAI TESQUE | 1G | EUR 53.2 |
Gentamicin Sulfate, Animal-Free |
|||
| 19771-14 | NACALAI TESQUE | 5G | EUR 168 |
Gentamicin Sulfate, Animal-Free |
|||
| 19771-72 | NACALAI TESQUE | 25G | EUR 630 |
Gentamicin Sulfate 10 mg/ml - 100ml |
|||
| LM-A4111/100 | Biosera France - Medical Scientific Equipment | 100ml | EUR 20.19 |
Gentamicin Sulfate 50 mg/ml - 100ml |
|||
| LM-A4112/100 | Biosera France - Medical Scientific Equipment | 100ml | EUR 30.25 |
Gentamicin C1 Sulfate EvoPure® |
|||
| G031-10MG | TOKU-E | 10 mg | EUR 581.77 |
|
Description: 38539-12-7 |
|||
Gentamicin C2 sulfate EvoPure® |
|||
| G033-10MG | TOKU-E | 10 mg | EUR 581.77 |
|
Description: 25876-11-3 (free base) |
|||
Gentamicin A sulfate EvoPure® |
|||
| G035-10MG | TOKU-E | 10 mg | EUR 318.2 |
|
Description: 13291-74-2 |
|||
Gentamicin X2 sulfate EvoPure® |
|||
| G036-2.5MG | TOKU-E | 2.5 mg | Ask for price |
|
Description: 36889-17-5 |
|||
Gentamicin X2 sulfate EvoPure® |
|||
| G036-PleaseContactusforPricing | TOKU-E | Please Contact us for Pricing | Ask for price |
|
Description: 36889-17-5 |
|||
Gentamicin Sulfate 10 mg/ml - 10ml |
|||
| LM-A4111/10 | Biosera France - Medical Scientific Equipment | 10ml | EUR 5.5 |
Gentamicin Sulfate 50 mg/ml - 10ml |
|||
| LM-A4112/10 | Biosera France - Medical Scientific Equipment | 10ml | EUR 6.11 |
Gentamicin Sulfate Solution(50mg/ml) |
|||
| 11980-14 | NACALAI TESQUE | 10ML | EUR 56 |
Gentamicin Sulfate Solution(10mg/ml) |
|||
| 16672-04 | NACALAI TESQUE | 10ML | EUR 16.1 |
Gentamicin Sulfate Salt (C Complex) (Alcomicin, Bristagen, Cidomycin, Duragentam, Garamycin, Garasol,) |
|||
| MBS6116877-25g | MyBiosource | 2.5(g | EUR 485 |
Gentamicin Sulfate Salt (C Complex) (Alcomicin, Bristagen, Cidomycin, Duragentam, Garamycin, Garasol,) |
|||
| MBS6116877-5x25g | MyBiosource | 5x2.5g | EUR 2025 |
10mL Gentamicin Sulfate Liquid 5 - PK10 |
|||
| 30-005-CR | Scientific Laboratory Supplies | PK10 | EUR 650.7 |
Gentamicin sulfate/Amphotericin (GA-1000) |
|||
| LOCC-4083 | Westburg | each | Ask for price |
Gentamycin (Gentamicin) Sulfate Solution 10mg/ml |
|||
| MBS651400-10x20mL | MyBiosource | 10x20mL | EUR 315 |
Gentamycin (Gentamicin) Sulfate Solution 10mg/ml |
|||
| MBS651400-20mL | MyBiosource | 20mL | EUR 160 |
Gentamycin (Gentamicin) Sulfate Solution 10mg/ml |
|||
| MBS651400-5x20mL | MyBiosource | 5x20mL | EUR 220 |
Gentamycin (Gentamicin) Sulfate Solution 50mg/ml |
|||
| MBS651312-10x20mL | MyBiosource | 10x20mL | EUR 970 |
Gentamycin (Gentamicin) Sulfate Solution 50mg/ml |
|||
| MBS651312-20mL | MyBiosource | 20mL | EUR 220 |
Gentamycin (Gentamicin) Sulfate Solution 50mg/ml |
|||
| MBS651312-5x20mL | MyBiosource | 5x20mL | EUR 610 |
Gentamicin C1a sulfate EvoPure® |
|||
| G032-10MG | TOKU-E | 10 mg | EUR 581.77 |
|
Description: 37713-04-5; 26098-04-4 (free base) |
|||
Gentamicin C2a sulfate EvoPure® |
|||
| G034-10MG | TOKU-E | 10 mg | EUR 581.77 |
|
Description: 38539-12-7; 59751-72-3 (free base) |
|||
Gentamicin C2b sulfate EvoPure® |
|||
| G062-10MG | TOKU-E | 10 mg | EUR 438.71 |
|
Description: 66803-19-8 |
|||
Gentamicin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40710024-1 | Bio-WORLD | 20 mL | EUR 55.09 |
Gentamicin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40710024-2 | Bio-WORLD | 100 mL | EUR 137.56 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-1 | Bio-WORLD | 20x1 mL | EUR 90.32 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-2 | Bio-WORLD | 20 mL | EUR 66.21 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-3 | Bio-WORLD | 50 mL | EUR 94.91 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-4 | Bio-WORLD | 100 mL | EUR 142.53 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-5 | Bio-WORLD | 100 mL | EUR 107.98 |
Gentamicin Sulfate Solution, 100mg/mL, Sterile |
|||
| 40120797-1 | Bio-WORLD | 20 mL | EUR 72.55 |
Gentamicin Sulfate Solution, 100mg/mL, Sterile |
|||
| 40120797-2 | Bio-WORLD | 100 mL | EUR 182.24 |
